Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to EVERGEN BIOTECHNOLOGIES, INC. for $140,000.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41HL080814-01 | Phase I | 140,000 | ||||||||
A SBIR Phase I contract was awarded to EVERGEN BIOTECHNOLOGIES, INC. for $114,760.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43RR020261-01 | Phase I | 114,760 | ||||||||
A SBIR Phase I contract was awarded to EVERGEN BIOTECHNOLOGIES, INC. for $132,680.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44HL091605-01 | Phase I | 132,680 | ||||||||
A SBIR Phase I contract was awarded to EVERGEN BIOTECHNOLOGIES, INC. for $140,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R41HL080814-01 | Phase I | 140,000 | ||||||||
A STTR Phase I contract was awarded to EVERGEN BIOTECHNOLOGIES, INC. for $166,000.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI069865-01 | Phase I | 166,000 | ||||||||
A SBIR Phase I contract was awarded to EVERGEN BIOTECHNOLOGIES, INC. for $175,144.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43RR023774-01A1 | Phase I | 175,144 | ||||||||
A SBIR Phase II contract was awarded to EVERGEN BIOTECHNOLOGIES, INC. for $1,185,145.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44HL091605-02 | Phase II | 1,185,145 | ||||||||
A SBIR Phase I contract was awarded to EVERGEN BIOTECHNOLOGIES, INC. for $166,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R41AI069865-01 | Phase I | 166,000 | ||||||||
A SBIR Phase I contract was awarded to EVERGEN BIOTECHNOLOGIES, INC. for $80,000.0 USD from the U.S. Department of Agriculture. | SBIR | 2005-33610-15607 | Phase I | 80,000 | ||||||||
A SBIR Phase II contract was awarded to EVERGEN BIOTECHNOLOGIES, INC. for $296,000.0 USD from the U.S. Department of Agriculture. | SBIR | 2006-33610-17252 | Phase II | 296,000 |